Summa Equity Fund II has acquired a majority stake in Singapore proteomics company Sengenics, paving the exit of SBI Islamic Fund II (Brunei).
SBI Islamic Fund II (Brunei) divested its 12.93 per cent stake in Sengenics to Summa Equity last month, the fund said in an undated press release on its website.
